Literature DB >> 1541484

Efficient expression of tum- antigen P91A by transfected subgenic fragments.

P Chomez1, E De Plaen, A Van Pel, C De Smet, J P Szikora, C Lurquin, A M Lebacq-Verheyden, T Boon.   

Abstract

Mutagen treatment of mouse P815 tumor cells produces immunogenic mutants that express new transplantation antigens (tum- antigens) recognized by cytolytic T cells. The gene encoding tum- antigen P91A comprises 12 exons and a mutation located in exon 4 is responsible for the production of a new antigenic peptide. Transfection experiments showed that the expression of the antigen could be transferred not only by the entire gene but also by gene segments comprising only the mutated exon and parts of the surrounding introns. This was observed with subgenic regions that were not cloned in expression vectors. Antigen expression did not require the integration of the transfected gene segment into a resident P91A gene by homologous recombination. It also occurred when the subgenic segment was transfected without the usual selective gene, which comprises an eucaryotic promoter, and also without plasmid sequences, which are known to contain weak promoters. When a stop codon was introduced at the beginning of exon 4, the expression of the antigen was maintained and evidence was obtained that an ATG codon located in this region served as initiation site for the translation of the antigenic peptide. But we have not obtained evidence indicating that antigenic peptides are direct translation products rather than degradation products of entire proteins.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1541484     DOI: 10.1007/bf00166829

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  39 in total

1.  Units of transcription and translation: sequence components of heterogeneous nuclear RNA and messenger RNA.

Authors:  B Lewin
Journal:  Cell       Date:  1975-02       Impact factor: 41.582

2.  Inhibition of restriction endonuclease Nci I cleavage by phosphorothioate groups and its application to oligonucleotide-directed mutagenesis.

Authors:  K L Nakamaye; F Eckstein
Journal:  Nucleic Acids Res       Date:  1986-12-22       Impact factor: 16.971

3.  The minimal number of class II MHC-antigen complexes needed for T cell activation.

Authors:  S Demotz; H M Grey; A Sette
Journal:  Science       Date:  1990-08-31       Impact factor: 47.728

4.  Determinants of rat albumin promoter tissue specificity analyzed by an improved transient expression system.

Authors:  J M Heard; P Herbomel; M O Ott; A Mottura-Rollier; M Weiss; M Yaniv
Journal:  Mol Cell Biol       Date:  1987-07       Impact factor: 4.272

5.  A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes.

Authors:  T Espevik; J Nissen-Meyer
Journal:  J Immunol Methods       Date:  1986-12-04       Impact factor: 2.303

6.  Selection of highly transfectable variant from mouse mastocytoma P815.

Authors:  A Van Pel; E De Plaen; T Boon
Journal:  Somat Cell Mol Genet       Date:  1985-09

7.  Lambda replacement vectors carrying polylinker sequences.

Authors:  A M Frischauf; H Lehrach; A Poustka; N Murray
Journal:  J Mol Biol       Date:  1983-11-15       Impact factor: 5.469

8.  Structure of the gene of tum- transplantation antigen P35B: presence of a point mutation in the antigenic allele.

Authors:  J P Szikora; A Van Pel; V Brichard; M André; N Van Baren; P Henry; E De Plaen; T Boon
Journal:  EMBO J       Date:  1990-04       Impact factor: 11.598

9.  Structure of the gene of tum- transplantation antigen P198: a point mutation generates a new antigenic peptide.

Authors:  C Sibille; P Chomez; C Wildmann; A Van Pel; E De Plaen; J L Maryanski; V de Bergeyck; T Boon
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

10.  Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. T lymphocyte-mediated cytolysis.

Authors:  T Boon; J Van Snick; A Van Pel; C Uyttenhove; M Marchand
Journal:  J Exp Med       Date:  1980-11-01       Impact factor: 14.307

View more
  4 in total

1.  Dose-dependent and schedule-dependent effects of interleukin-12 on antigen-specific CD8 responses.

Authors:  K Lee; W W Overwijk; M O'Toole; H Swiniarski; N P Restifo; A J Dorner; S F Wolf; K Sturmhoefel
Journal:  J Interferon Cytokine Res       Date:  2000-06       Impact factor: 2.607

2.  Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype.

Authors:  T E Sparer; S G Wynn; D J Clark; J M Kaplan; L M Cardoza; S C Wadsworth; A E Smith; L R Gooding
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

3.  The class I antigen-processing pathway for the membrane protein tyrosinase involves translation in the endoplasmic reticulum and processing in the cytosol.

Authors:  C A Mosse; L Meadows; C J Luckey; D J Kittlesen; E L Huczko; C L Slingluff; J Shabanowitz; D F Hunt; V H Engelhard
Journal:  J Exp Med       Date:  1998-01-05       Impact factor: 14.307

4.  A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E.

Authors:  C Traversari; P van der Bruggen; I F Luescher; C Lurquin; P Chomez; A Van Pel; E De Plaen; A Amar-Costesec; T Boon
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.